273 related articles for article (PubMed ID: 25410486)
1. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
2. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
3. Current status and future trends in cervical cancer screening.
Castle P; Dowdall M
Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
[No Abstract] [Full Text] [Related]
4. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
5. Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
Austin RM; Onisko A; Zhao C
J Am Soc Cytopathol; 2020; 9(6):602-606. PubMed ID: 32839150
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States.
Roland KB; Soman A; Benard VB; Saraiya M
Am J Obstet Gynecol; 2011 Nov; 205(5):447.e1-8. PubMed ID: 21840492
[TBL] [Abstract][Full Text] [Related]
7. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
Shin HY; Lee B; Hwang SH; Lee DO; Sung NY; Park JY; Jun JK
J Gynecol Oncol; 2019 Sep; 30(5):e76. PubMed ID: 31328458
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
Tsiambas E; Riziotis C
Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686
[TBL] [Abstract][Full Text] [Related]
10. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
Sawaya GF
Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
[No Abstract] [Full Text] [Related]
11. Screening for Cervical Cancer.
Jin J
JAMA; 2018 Aug; 320(7):732. PubMed ID: 30140878
[No Abstract] [Full Text] [Related]
12. Cutting cervical cancer: organizations and researchers strive to improve screening, prevention.
Printz C
Cancer; 2014 Aug; 120(16):2381-2. PubMed ID: 25099731
[No Abstract] [Full Text] [Related]
13. [Papsmears: An endless story of an announced death?].
Cochand-Priollet B
Ann Pathol; 2019 Dec; 39(6):375-377. PubMed ID: 31839115
[No Abstract] [Full Text] [Related]
14. Exhortations to abandon the Pap test as a routine initial cervical screening test are still premature and carry significant risks.
Austin RM
Diagn Cytopathol; 2010 Nov; 38(11):783-7. PubMed ID: 20607804
[No Abstract] [Full Text] [Related]
15. Whatever happened to the annual pap smear?
Vigliani MB
R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
[No Abstract] [Full Text] [Related]
16. Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today.
Nayar R; Goulart RA; Tiscornia-Wasserman PG; Davey DD
Cancer Cytopathol; 2014 Oct; 122(10):720-9. PubMed ID: 25228434
[No Abstract] [Full Text] [Related]
17. Perceived effectiveness of HPV test as a primary screening modality among US providers.
Cooper CP; Saraiya M
Prev Med; 2015 Sep; 78():33-7. PubMed ID: 26116889
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
Madzima TR; Vahabi M; Lofters A
Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
[TBL] [Abstract][Full Text] [Related]
19. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
20. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
